4.6 Article

The spectrum of histopathological features in acute generalized exanthematous pustulosis: a study of 102 cases

Journal

BRITISH JOURNAL OF DERMATOLOGY
Volume 163, Issue 6, Pages 1245-1252

Publisher

WILEY
DOI: 10.1111/j.1365-2133.2010.09967.x

Keywords

acute generalized exanthematous pustulosis; AGEP; cutaneous adverse drug reaction; histopathology

Categories

Funding

  1. ADIR Cie
  2. Bayer Pharma AG/Vital
  3. Boehringer Ingelheim
  4. Cassenne
  5. Ciba Geigy/Novartis
  6. Cilag GmbH
  7. Dr Willmar Schwabe
  8. Goedecke Parke Davis
  9. Glaxo Wellcome/GlaxoSmithKline
  10. Hoechst AG/Hoechst Marion Roussel/Aventis
  11. Hoffmann-La Roche
  12. IRIS Servier
  13. Jouveinal Lab.
  14. LEO
  15. LILLY
  16. MSD Sharp Dohme
  17. Pfizer
  18. Rhone Poulenc Rorer
  19. Sanofi Winthrop/Sanofi Synthelabo GmbH
  20. Schering AG
  21. Pharmaceutical Companies in France
  22. INSERM (Institutde la Sante et de la Recherche Medicale)
  23. French Ministry of Health [PHRC AOM 98027]
  24. Federal Institute for Drugs and Medical Devices (BfArM)
  25. European Commission [QLRT-2002-01738]
  26. GIS-Institut des Maladies Rares and INSERM in France [4CH09G]
  27. DFG in Germany [FOR 534]
  28. Bayer/Vital
  29. GlaxoSmithKline
  30. MSD Sharp and Dohme
  31. Merck Novartis
  32. Roche
  33. Sanofi-Aventis
  34. Servier

Ask authors/readers for more resources

Background Acute generalized exanthematous pustulosis (AGEP) is a rare severe pustular reaction pattern with a typical clinical picture. Objectives To characterize the histopathological features of AGEP in a large series of cases with a validated diagnosis. Methods A multinational retrospective histopathological study was conducted. It included 102 hospitalized patients (recruited within the EuroSCAR and RegiSCAR studies) with a validated diagnosis of probable or definite AGEP. A systematic description of the histopathological features in AGEP was done based on a standardized grading system. Results Sub/intracorneal pustules (41%), intraepidermal pustules (20%) or combinations of them (38%) were observed in 102 cases. The pustules were usually large (> 15 keratinocytes) (82% and 89%, respectively) and regularly contained eosinophils (36% and 32%, respectively). Spongiform features were less prominent in the sub/intracorneal pustules compared with the intraepidermal pustules (44% and 95%, respectively). The main epidermal features were necrotic keratinocytes (67%), including incidental segmental necrosis (7%), and spongiosis (80%) with neutrophil exocytosis (77%). The main dermal features were papillary oedema (88%) and mixed superficial (100%), interstitial (93%), and mid/deep-dermal infiltrates (95%) containing neutrophils (100%) and eosinophils (81%). Follicular pustules were also seen (23%), but vasculitis generally was absent. Classical features of plaque-type psoriasis were infrequent and usually mild. No significant differences were observed between a subgroup of 16 cases with and 86 cases without psoriasis. Conclusions The present histopathological study concerns a large series of cases with a validated diagnosis of AGEP. It provides diagnostic clues in favour of AGEP in patients with a pustular eruption.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available